Renal dysfunction after vascular surgery

Current Opinion in Anaesthesiology

Volumn 16, Issue 1, 2003, Pages 45-51

  Swaminathan, Madhav ^a   Stafford Smith, Mark ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Postoperative complications; Renal failure; Vascular surgery

Indexed keywords

APOLIPOPROTEIN E;

ANEURYSM SURGERY; DISEASE COURSE; EMBOLISM; ENDOVASCULAR SURGERY; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; HYPOVOLEMIA; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY ISCHEMIA; MINIMALLY INVASIVE SURGERY; PATHOPHYSIOLOGY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TREATMENT PLANNING; VASCULAR SURGERY;

EID: 0037319428     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200302000-00007     Document Type: Review

References (50)

1. Godet G, Fleron MH, Vicaut E, et al. Risk factors for acute postoperative renal failure in thoracic or thoracoabdominal aortic surgery: a prospective study. Anesth Analg 1997; 85:1227-1232.
2. Rectenwald JE, Huber TS, Martin TD, et al. Functional outcome after thoracoabdominal aortic aneurysm repair. J Vasc Surg 2002; 35:640-647. This paper discusses intraoperative and postoperative factors affecting survival and functional outcome one year after AAA repair. It points to postoperative renal dysfunction as a prognostic indicator of poor outcome.
3. Huynh TT, Miller III CC, Estrera AL, et al. Determinants of hospital length of stay after thoracoabdominal aortic aneurysm repair. J Vasc Surg 2002; 35:648-653. The authors comprehensively describe the factors contributing to increased length of stay after TAAA repair in 540 patients over a 10-year period. They also found postoperative renal dysfunction to be a major independent predictor of length of stay after surgery.
4. Carpenter JP, Fairman RM, Barker CF, et al. Endovascular AAA repair in patients with renal insufficiency: strategies for reducing adverse renal events. Cardiovasc Surg 2001; 9:559-564. In this paper, the authors describe the use of non-ionic radiocontrast or magnetic resonance angiography as effective strategies for reducing postoperative renal dysfunction, especially in high-risk patients.
5. Coselli JS, LeMaire SA, Conklin LD, et al. Morbidity and mortality after extent II thoracoabdominal aortic aneurysm repair. Ann Thorac Surg 2002; 73:1107-1115. An excellent review of factors associated with adverse outcome after TAAA repair in 442 patients. The authors also provide a discussion of other studies in the same area and point to several postoperative complications that are associated with mortality.
6. Hertzer NR, Mascha EJ, Karafa MT, et al. Open infrarenal abdominal aortic aneurysm repair: the Cleveland Clinic experience from 1989 to 1998. J Vasc Surg 2002; 35:1145-1154. These authors describe a single-center experience with open AAA repair in 1135 patients followed-up for a median duration of nearly 5 years after surgery. They also provide a comprehensive discussion of the benefits and indications for endovascular versus open repair based on preoperative risk profiles and current data on postoperative complications with both techniques.
7. Kazui T, Washiyama N, Bashar AH, et al. Surgical outcome of acute type A aortic dissection: analysis of risk factors. Ann Thorac Surg 2002; 74:75-81. This paper describes the risk factors for morbidity and mortality after acute aortic dissection. Pre-existing renal ischemia is noted to be an adverse prognostic indicator.
8. Cittanova ML, Zubicki A, Savu C, et al. The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function. Anesth Analg 2001; 93:1111-1115. In this interesting prospective study, the authors describe chronic preoperative treatment with angiotensin-converting enzyme inhibitors as the only risk factor for postoperative renal dysfunction after abdominal and thoracoabdominal aortic surgery in 249 patients.
9. Schepens MA, Defauw JJ, Hamerlijnck RP, Vermeulen FE. Risk assessment of acute renal failure after thoracoabdominal aortic aneurysm surgery. Ann Surg 1994; 219:400-407.
10. Kashyap VS, Cambria RP, Davison JK, l'Italien GJ. Renal failure after thoracoabdominal aortic surgery. J Vasc Surg 1997; 26:949-955.
11. Cavillon A, Melliere D, Allaire E, et al. Are femoro-infrapopliteal bypasses worthwhile for limb salvage? J Cardiovasc Surg (Torino) 1998; 39:267-272.
12. Lifeline Registry of Endovascular Aneurysm Repair: Registry data report. J Vasc Surg 2002; 35:616-620. This is the first report of the only registry for endovascular aneurysm repair currently in operation. The significant finding of this analysis of 1646 endovascular repair patients is that postoperative renal dysfunction continues to be an important factor predicting mortality at one year.
13. Conlon PJ, Stafford-Smith M, White WD, et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant 1999; 14:1158-1162.
14. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation 1997; 95:878-884.
15. Kang DH, Anderson S, Kim YG, et al. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 2001; 37:601-611. The authors describe the important concept of impaired expression of VEGF in the renal medulla of aging kidneys in a rat model.
16. Choi YJ, Chakraborty S, Nguyen V, et al. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol 2000; 31:1491-1497.
17. Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995; 332:647-655.
18. Heyman SN, Reichman J, Brezis M. Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. Invest Radiol 1999; 34:685-691.
19. Mackensen G, Ti L, Swaminathan M, et al. Apolipoprotein E phenotype influences the effect of ascending aorta atheroma burden on peak postoperative serum creatinine following CABG surgery [abstract]. Anesth Analg 2001; 92:SCA 46. This study is the first to describe an association between postoperative renal dysfunction in coronary artery bypass graft patients and a genetic predisposition that influences the location and effect of aortic atherosclerosis.
20. Davila-Roman VG, Kouchoukos NT, Schechtman KB, Barzilai B. Atherosclerosis of the ascending aorta is a predictor of renal dysfunction after cardiac operations. J Thorac Cardiovasc Surg 1999; 117:111-116.
21. Kumral E, Balkir K, Yagdi T, et al. Microembolic signals in patients undergoing coronary artery bypass grafting. Effect of aortic atherosclerosis. Tex Heart Inst J 2001; 28:16-20. This article adds to evidence that aortic atherosclerosis is a potent precursor for the embolic phenomenon. Although described in this study as a risk factor for stroke, athero-emboli may also be equally damaging for other organs.
22. Stabellini N, Cerretani D, Russo G, et al. Renal atheroembolic disease: evaluation of the efficacy of corticosteroid therapy. G Ital Nefrol 2002; 19:18-21.
23. Modi KS, Rao VK. Atheroembolic renal disease. J Am Soc Nephrol 2001; 12:1781-1787. This is an excellent review of atheroembolic renal disease, an important complication of aortic surgery.
24. Nakatsuka M. Assessment of gut mucosal perfusion and colonic tissue blood flow during abdominal aortic surgery with gastric tonometry and laser Doppler flowmetry. Vasc Endovasc Surg 2002; 36:193-198. In this small prospective study in eight patients undergoing infrarenal AAA repair, the authors describe the decrease in gastric pH during aortic occlusion as an index of impaired gut perfusion. The findings of this study add to concerns that impaired gut perfusion does occur during aortic occlusion that may lead to postoperative complications.
25. Elmarasy NM, Soong CV, Walker SR, et al. Sigmoid ischemia and the inflammatory response following endovascular abdominal aortic aneurysm repair. J Endovasc Ther 2000; 7:21-30.
26. Lau LL, Halliday MI, Lee B, et al. Intestinal manipulation during elective aortic aneurysm surgery leads to portal endotoxaemia and mucosal barrier dysfunction. Eur J Vasc Endovasc Surg 2000; 19:619-624. In this elegant prospective, randomized study, the authors found that the transperitoneal surgical approach is associated with increased portal endotoxemia. This is an important finding that implies that an altered surgical approach may be beneficial to the outcome of the procedure.
27. Badr KF. Sepsis-associated renal vasoconstriction: potential targets for future therapy. Am J Kidney Dis 1992; 20:207-213.
28. Wardle EN. Acute renal failure and multiorgan failure. Nephron 1994; 66:380-385.
29. Welborn MB, Oldenburg HS, Hess PJ, et al. The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair. Crit Care Med 2000; 28:3191-3197.
30. Sasaki T, Ohsawa S, Ogawa M, et al. Postoperative renal function after an abdominal aortic aneurysm repair requiring a suprarenal aortic cross-clamp. Surg Today 2000; 30:33-36.
31. Sweeney KJ, Evoy D, Sultan S, et al. Endovascular approach to abdominal aortic aneurysms limits the postoperative systemic immune response. Eur J Vasc Endovasc Surg 2002; 23:303-308. This paper suggests that the endovascular approach to aortic aneurysm repair is associated with a reduced inflammatory response, as evidenced by lowered T-cell activation in this group of patients compared with the open approach. This finding adds to suggestions that a less invasive approach may be favorable in high-risk patients.
32. Bolke E, Jehle PM, Storck M, et al. Endovascular stent-graft placement versus conventional open surgery in infrarenal aortic aneurysm: a prospective study on acute phase response and clinical outcome. Clin Chim Acta 2001; 314:203-207. An excellent prospective study that describes not only a reduced pro-inflammatory response, but also beneficial clinical outcomes in AAA patients undergoing endovascular repair compared with open surgery.
33. Strittmatter WJ, Bova Hill C. Molecular biology of apolipoprotein E. Curr Opin Lipidol 2002; 13:119-123.
34. Hanon O, Girerd X, Luong V, et al. Association between the apolipoprotein E polymorphism and arterial wall thickness in asymptomatic adults. J Hypertens 2000; 18:431-436.
35. Gerdes LU, Lindholt JS, Vammen S, et al. Apolipoprotein E genotype is associated with differential expansion rates of small abdominal aortic aneurysms. Br J Surg 2000; 87:760-765.
36. Chen G, Paka L, Kako Y, et al. A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J Biol Chem 2001; 276:49142-49147. In this study, the authors found an important physiological basis for the renoprotective role of ApoE.
37. Chew ST, Newman MF, White WD, et al. Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 2000; 93:325-331.
38. Wijnen MH, Cuypers P, Buth J, et al. Differences in renal response between endovascular and open repair of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2001; 21:171-174. This is an important paper that points to the fact that the endovascular technique is also associated with a significant degree of ischemia-reperfusion injury that may add to postoperative renal dysfunction.
39. Wahlberg E, Dimuzio PJ, Stoney RJ. Aortic clamping during elective operations for infrarenal disease: the influence of clamping time on renal function. J Vasc Surg 2002; 36:13-18. This is an excellent retrospective review of infrarenal aortic surgery patients in which the authors found a strong association between the duration of aortic occlusion and postoperative renal dysfunction.
40. Koksoy C, LeMaire SA, Curling PE, et al. Renal perfusion during thoracoabdominal aortic operations: cold crystalloid is superior to normothermic blood. Ann Thorac Surg 2002; 73:730-738. The authors describe the effect of a selected surgical intervention in patients undergoing TAAA repair. This paper provides an interesting insight into intraoperative renoprotective strategies.
41. Deriu GP, Grego F, Lepidi S, et al. Short-term arterial blood reperfusion of normothermic kidney in renal artery and abdominal aorta reconstructive surgery. Eur J Vasc Endovasc Surg 2001; 21:314-319. This is another study describing the beneficial effects of a surgical intervention on postoperative renal dysfunction.
42. Marik PE. Low-dose dopamine: a systematic review. Intens Care Med 2002; 28:877-883. This review is an excellent mete-analysis of studies that have investigated low-dose dopamine as a renoprotective drug.
43. Woo EB, Tang AT, el-Gamel A, et al. Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction? Eur J Cardiothorac Surg 2002; 22:106-111. Another study that failed to find a renoprotective role for dopamine, this time in cardiac surgery utilizing cardiopulmonary bypass.
44. Chamsuddin AA, Kowalik KJ, Bjarnason H, et al. Using a dopamine type IA receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy. Am J Roentgenol 2002; 179:591-596.
45. Tumlin JA, Wang A, Murray PT, Mathur VS. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Am Heart J 2002; 143:894-903.
46. Halpenny M, Rushe C, Breen P, et al. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 2002; 19:32-39. This is the first published randomized clinical trial of fenoldopam in aortic surgical patients. The authors attribute a renoprotective role to fenoldopam in this trial involving 28 patients undergoing infrarenal aortic surgery.
47. Stephens CT, Jandhyala BS. Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats. Clin Exp Hypertens 2002; 24:301-313. In this rat model of ischemia-reperfusion, the authors found that fenoldopam was associated with increased tubular injury. This adds to the current concerns about the clinical usage of this drug in the United States.
48. Lee HT, Emala CW. Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation. Am J Kidney Dis 2001; 38:610-618.
49. 2A adenosine receptor: a novel therapeutic target in renal disease. Am J Physiol Renal Physiol 2002; 282:F10-F18. This review article gives an excellent account of specific adenosine receptor activation as an anti-inflammatory therapeutic target in renal disease.
50. Wijnen MH, Roumen RM, Vader HL, Goris RJ. A multiantioxidant supplementation reduces damage from ischaemia reperfusion in patients after lower torso ischaemia. A randomised trial. Eur J Vasc Endovasc Surg 2002; 23:486-490. The authors describe the beneficial effects of anti-oxidant therapy in reducing organ injury mediated by oxygen-derived free radicals. Although not directly associated with reduced renal injury, a lowered 'systemic response' is implied.